Evidence of metabolic syndrome in lean children with premature pubarche at diagnosis

Metabolism: Clinical and Experimental

Volumn 57, Issue 6, 2008, Pages 733-740

  Mathew, Revi P ^a   Byrne, Daniel W ^a   Linton, MacRae F ^a   Vaughan, Douglas E ^a   Fazio, Sergio ^a   Russell, William E ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 8; PRASTERONE SULFATE; TUMOR NECROSIS FACTOR ALPHA;

ANTHROPOMETRY; ARTICLE; BODY FAT DISTRIBUTION; BODY HEIGHT; BODY MASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; LEAN BODY WEIGHT; LIPID BLOOD LEVEL; LIPID STORAGE; MALE; MEAN ARTERIAL PRESSURE; METABOLIC SYNDROME X; PARAMETER; PELVIC GIRDLE; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; SKELETAL MUSCLE; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

BODY MASS INDEX; CHILD; CHOLESTEROL; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMANS; LIPOPROTEINS, HDL; MALE; METABOLIC SYNDROME X; PUBERTY, PRECOCIOUS; THINNESS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 43849107760     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.01.010     Document Type: Article

References (56)

1. Saenger P., and Reiter E. Premature adrenarche: a normal variant of puberty. J Clin Endocrinol Metab 74 (1992) 236-238
2. Reiter E. Premature adrenarche. Endocrinologist 7 (1997) 85
3. Ibanez L., de Zegher F., and Potau N. Premature pubarche, ovarian hyperinsulinism, hyperandrogenism and the polycystic ovary syndrome: from a complex constellation to a simple sequence of prenatal onset. J Endocrinol Invest 21 (1998) 558-566
4. Rittmaster R., Deshwal N., and Lehman L. The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovary syndrome. J Clin Endocrinol Metab 76 (1993) 1295-1299
5. DiMartino-Nardi J. Premature adrenarche: findings in prepubertal African American and Caribbean-Hispanic girls. Acta Paediatr Suppl 433 (1999) 67-72
6. Eckel R., Grundy S., and Zimmet P. The metabolic syndrome. Lancet 365 (2005) 1415-1428
7. Jones K. The dilemma of the metabolic syndrome in children and adolescents: disease or distraction?. Pediatr Diabetes 7 (2006) 311-321
8. Adults., E.P.o.D.E.a.T.o.H.B.C.i., Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
9. Cook S., et al. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third national health and nutrition examination survey. 1988-1994. Arch Pediatr Adolesc Med 157 (2003) 821-827
10. De Ferranti S., et al. Prevalence of metabolic syndrome in American adolescents. Circulation 110 (2004) 2494-2497
11. Goodman E., et al. Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents. J Pediatr 145 (2004) 445-451
12. Weiss R., et al. Obesity and metabolic syndrome in children and adolescents. N Engl J Med 350 (2004) 2362-2374
13. Alberti K., Zimmet P., and Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 366 (2005) 1059-1062
14. Grundy S. Metabolic syndrome: a multiplex of cardiovascular risk factor. J Clin Endocrinol Metab 92 2 (2007) 399-404
15. Ferrannini E. Metabolic syndrome: solution in search of a problem. J Clin Endocrinol Metab 92 2 (2007) 396-398
16. Denburg M., et al. Insulin sensitivity and the insulin-like growth factor system in prepubertal boys with premature pubarche. J Clin Endocrinol Metab 87 (2002) 5604-5609
17. Ibanez L., et al. Fat distribution in non-obese girls with and without precocious pubarche: central adiposity related to insulinaemia and androgenaemia from prepuberty to postmenarche. Clin Endocrinol 58 (2003) 372-379
18. Bouchard C., Bray G.A., and Hubbard V.S. Basic and clinical aspects of regional fat distribution. Am J Clin Nutr 52 (1990) 946-950
19. Daniels S., et al. Association of body fat distribution and cardiovascular risk factors in children and adolescents. Circulation 99 (1999) 541-545
20. Walton C., et al. Body fat distribution, rather than overall adiposity, influences serum lipids and lipoproteins in healthy men independent of age. Am J Med 99 (1995) 459-464
21. Ashwell M. Obesity in men and women. Int J Obes Relat Metab Disord 18 (1994) S1-S7
22. Smoak C., et al. Relation of obesity to clustering of cardiovascular disease risk factors in children and young adults. The Bogalusa Heart Study. Am J Epidemiol 125 (1987) 364-372
23. Sardinha L., et al. Subcutaneous central fat is associated with cardiovascular risk factors in men independently of total fatness and fitness. Metabolism 49 (2000) 1379-1385
24. Ibanez L., et al. Hyperinsulinemia, dyslipidemia and cardiovascular risk in girls with a history of premature pubarche. Diabetologica 41 (1998) 1057-1063
25. Freedman D., et al. Inter-relationships among childhood BMI, childhood height, and adult obesity: the Bogalusa Heart Study. Int J Obes 28 (2004) 10-16
26. Thompson D., et al. Childhood overweight and cardiovascular disease risk factors: the National Heart, Lung, Blood Institute Growth and Health Study. J Pediatr 150 (2007) 18-25
27. Herman-Giddens M., et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the pediatric research in office settings network. Pediatrics 99 (1997) 505-512
28. Mathew R., et al. Premature pubarche in girls is associated with functional adrenal, but not ovarian, hyperandrogenism. J Pediatr 102 (2002) 91-98
29. Marshall W., and Tanner J. Variations in pattern of pubertal changes in girls. Arch Dis Child 44 (1969) 291-303
30. Grinstein G., et al. The relationship between birth weight (BW), body mass index (BMI) and insulin sensitivity (SI) in prepubertal Caribbean Hispanic (CH) and black African American (BAA) girls with premature pubarche. Pediatr Res 45 (1999) 89 [abstract]
31. Allain C., et al. Enzymatic determination of total serum cholesterol. Clin Chem 20 (1974) 470-475
32. Fossati P., and Prencipe L. Serum triglycerides determined calorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 28 (1982) 2077-2080
33. Teitz N. Clincal guide to laboratory tests. Vol. 3rd ed. (1995), Saunders, Philadelphia, PA
34. Guven A., Cinaz P., and Bideci A. Is premature pubarche a risk factor of atherogenesis?. Pediatr Int 47 (2005) 20-25
35. Flier J., and Foster D. Eating disorders: obesity, anorexia nervosa, and bulimia nervosa in William textbook of endocrinology. In: Flier J. (Ed). Eating disorders: obesity, anorexia nervosa, and bulimia nervosa. 9th ed. (1998), Saunders, Philadelphia, PA
36. Michels K., Greenland S., and Rosner B. Does body mass index adequately capture the relation of body composition and body size to health outcomes?. Am J Epidemiol 147 (1998) 167-172
37. Saenger P., and DiMartino-Nardi J. Premature adrenarche. J Endocrinol Invest 24 (2001) 724-733
38. Orchard T., et al. Plasma insulin and lipoprotein concentrations: and atherogenic association. J Epidemiol 118 (1983) 326-337
39. Abbott W., Lillioja S., and Young A. Relationship between plasma lipoprotein concentrations and insulin action in obese hyperinsulinemic population. Diabetes 36 (1987) 897-904
40. Laakso M., Sarlund H., and Mykkanen L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose intolerance. Atherosclerosis 10 (1990) 223-231
41. Laws A., and Reaven G. Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations. J Inern Med 231 (1992) 25-30
42. McLaughlin T., et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Int Med 139 (2003) 802-809
43. Lambrinoudaki I., et al. Body composition assessment by dual-energy X-ray absorptiometry: comparison of prone and supine measurements. Metabolism 47 (1998) 1379-1382
44. Newton R., et al. Percent body fat measured by BIA and DEXA in obese, African-American adolescent girls. Int J of Obesity 29 (2005) 594-602
45. Wake D., et al. Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity. Clin Endocrinol 66 (2007) 440-446
46. Marin P., and Bjorntorp P. Endocrine-metabolic patterns and adipose tissue distribution. Horm Res 39:81-85 39 (1993) 81-85
47. Rosenbaum M., and Leibel R. Role of gonadal steroids in the sexual dimorphisms in body composition and circulating concentrations of leptin. J Clin Endocrinol Metab 77 (1999) 1041-1045
48. Klein K., et al. Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. J Clin Invest 94 (1994) 2475-2480
49. Salmenniemi U., et al. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation 110 (2004) 3842-3848
50. Schimidt M., et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities Study): a cohort study. Lancet 353 (1999) 1649-1652
51. Rifai N., and Ridker P. Inflammatory markers and coronary heart disease. Curr Opin Lipidol 13 (2002) 383-389
52. Arslanian S., and Suprasongsin C. Insulin sensitivity, lipids, and body composition in childhood. Is "syndrome X" present?. J Clin Endocrinol Metab 81 (1996) 1058-1062
53. Ronnemaa T., et al. Serum insulin and other cardiovascular risk indicators in children, adolescents and young adults. Ann Med 23 (1991) 63-72
54. Freemark M., and Bursey D. The effect of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics 107 (2001) E55
55. Kay J., et al. Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Metabolism 50 (2001) 1457-1461
56. Bondeson J., and Maini R. Tumor necrosis factor as a therapeutic target in rheumatoid arthritis and other chronic inflammatory diseases: the clinical experience with infliximab (Remicade). Int J Clin Pract 55 (2001) 211-216